معرفی
Dr. Brett Schwartz is a Senior Research Fellow at the Research School of Chemistry, Australian National University, with expertise in organic chemistry, biochemistry, and chemical synthesis. He has collaborated extensively on projects related to enzymatic interactions, peptide modification, and heparanase inhibition.
- PhD from University of Queensland (UQ)
Research Interests:
His work spans enzymology, glycobiology, and medicinal chemistry, focusing on:
- Nicotinamide cofactor biomimetics and alcohol dehydrogenase activity
- Development of glycomimetics for heparanase inhibition
- Peptide synthesis and sulfated xylooligosaccharide conformational analysis
- Bicyclobutane-triazolinedione cycloadditions for molecular engineering
Recent Publication Trends:
Over the last five years, his research has emphasized therapeutic glycomimetics (heparanase inhibitors), peptide sulfation strategies, and chemical synthesis innovations using cycloadditions.
Collaborative Projects:
He is actively involved in international collaborations and has contributed to projects involving:
- High-pressure chemical synthesis reactors
- Supercritical fluid chromatography for enantiopurity analysis
- Commercialization of heparanase inhibitors through Beta Therapeutics
